优化芝麻四重疗法和标准基于克拉里胺的三重疗法之间的比较,用于一线杆菌根除:双盲随机对照试验
Patricio Andrés Medel-Jara1,2,3, Gonzalo Latorre4, Eduardo Fuentes-Lopez5
1Facultad de Medicina, Programa de Doctorado en Epidemiología, Pontificia Universidad Católica de Chile, Santiago, Chile.
Lancet regional health. Americas
|December 9, 2025
概括
在智利,优化木四重疗法提供了比标准三重疗法更高的Helicobacter pylori根除率. 这种疗法是安全有效的,特别是在克拉里胺素耐药性普遍存在的地方.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
背景情况:
- 消除Helicobacter pylori对于预防胃潰瘍疾病和胃癌至关重要.
- 在智利,标准的三重疗法的有效性已经下降到建议的80%门以下.
- 优化木四倍疗法提供了一个替代的治疗策略.
研究的目的:
- 在智利人群中比较优化木四倍疗法与标准三倍疗法对H. pylori根除的疗效.
- 评估根除率,治疗成功率和与这两种疗法相关的不良事件.
主要方法:
- 一项随机双盲临床试验,涉及127名活跃H. pylori感染的未经治疗的患者.
- 参与者接受了14天优化木四倍疗法或标准三倍疗法.
- 治疗后至少4周评估了H. pylori的根除;评估了克拉里素耐药性和CYP2C19的基因型/表型.
主要成果:
- 在意向治疗分析 (p = 0.033) 中,优化木四倍疗法实现了显著更高的根除率 (95%) 与标准三倍疗法 (81%) 相比.
- 这两组的不良事件发生率相似 (67%对66%,p=1.00).
- 在基线清红素耐药性或CYP2C19多态性之间没有观察到显著的差异.
结论:
- 优化木四重疗法证明了比H.pylori的标准三重疗法更高的根除疗效.
- 优化的治疗方案是一种安全可靠的经验性治疗选择,特别是在高克拉里菌素耐药性区域.
- 这一发现对智利和类似地区的H. pylori治疗指南有重大影响.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
01:26Peptic Ulcer Disease IV: Management
406
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
406
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
507
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507
01:28Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
01:23Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
899
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
899